推荐产品
蒸汽压
23.3 mmHg ( 30 °C)
质量水平
方案
33-37% (by potassium permanganate, titration)
表单
liquid
包含
inhibitor
反应适用性
reagent type: oxidant
浓度
35 wt. % in H2O
折射率
n20/D 1.357
沸点
126 °C
mp
−40 °C
正在寻找类似产品? 访问 产品对比指南
一般描述
过氧化氢溶液产品是35%的过氧化氢水溶液。它通常用作绿色氧化剂,并且是比其他氧化剂更好的选择,因为它具有高活性氧含量,且副产物是水。[1]
包装
M-Bottle for Solvents
As a global leader in lab reagents, we are constantly looking for new ways to optimize the safety of our products. The newly developed 4L solvent bottle design features advanced sealing technology that eliminates leaks to make the handling of solvents safer and more convenient than ever before.
See all the new features here!
As a global leader in lab reagents, we are constantly looking for new ways to optimize the safety of our products. The newly developed 4L solvent bottle design features advanced sealing technology that eliminates leaks to make the handling of solvents safer and more convenient than ever before.
See all the new features here!
警示用语:
Danger
危险分类
Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
5.1B - Oxidizing hazardous materials
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
危险化学品
易制爆化学品
Integrated thermodynamic and kinetic model of homogeneous catalytic N-oxidation processes
Wang J, et al.
AIChE Journal, 66(4), e16875-e16875 (2020)
Understanding the cross-linking reactions in highly oxidized graphene/epoxy nanocomposite systems
Vryonis O, et al.
Journal of Materials Science, 54(4), 3035-3051 (2019)
V-, Mo-and W-containing layered double hydroxides as effective catalysts for mild oxidation of thioethers and thiophenes with H2O2
Maciuca AL, et al.
Catalysis Today, 138(1-2), 33-37 (2008)
Shoichi Iriguchi et al.
Blood, 125(2), 370-382 (2014-10-29)
Although overexpression of T-bet, a master transcription factor in type-1 helper T lymphocytes, has been reported in several hematologic and immune diseases, its role in their pathogenesis is not fully understood. In the present study, we used transgenic model mice
James R Van Brocklyn et al.
Cancer research, 74(19), 5364-5370 (2014-08-12)
Glioblastoma remains a devastating disease for which novel therapies are urgently needed. Here, we report that the Aurora-A kinase inhibitor alisertib exhibits potent efficacy against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo. Many glioblastoma neurosphere cells treated
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持